BackInstadose Pharma Overview

Instadose Pharma Accounts Payable

Instadose Pharma's accounts payable is $5M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$5.01M
↑ 350146.47% YoYΔ $5.00M vs prior year quarter

Peer trimmed avg / median

Loading

Instadose Pharma Accounts Payable History

Loading

Instadose Pharma vs. peers: Accounts Payable Comparison

Loading

Instadose Pharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Instadose Pharma (INSD) FAQ

Instadose Pharma (INSD) currently reports a accounts payable of $5M as of February 2022. That compares with $1.4K in the prior-year period — up 350146.5% year over year. Use the charts on this page to explore Instadose Pharma's accounts payable history and peer comparisons.

Instadose Pharma's accounts payable increased from $1.4K to $5M — a 350146.5% year-over-year increase (period ending February 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Instadose Pharma reported $5M in accounts payable as of February 2022. That compares with $1.4K in the prior-year period — up 350146.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Instadose Pharma, and consider following INSD for alerts when major investors trade the stock.

Questions & Answers